SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Shah Keeren Rameshchandra (Last) (First) (Middle) C/O TIZIANA LIFE SCIENCES LTD 14-15 CONDUIT STREET (Street) LONDON X0 W1S 2XJ (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026	3. Issuer Name and Ticker or Trading Symbol Tiziana Life Sciences Ltd [ TLSA ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner Officer (give title below) Other (specify below) CHIEF OPERATING & FIN. OFFICER	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
COMMON STOCK	2,500	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	05/06/2021	05/06/2030	common stock	15,625	0.88	D
Options	05/06/2022	05/06/2030	common stock	15,625	0.88	D
Options	05/06/2023	05/06/2030	common stock	15,625	0.88	D
Options	05/06/2024	05/06/2030	common stock	15,625	0.88	D
Options	03/14/2024	03/14/2033	common stock	46,875	0.57	D
Options	03/14/2025	03/14/2033	common stock	46,875	0.57	D
Options	03/14/2026	03/14/2033	common stock	46,875	0.57	D
Options	03/14/2027	03/14/2033	common stock	46,875	0.57	D
Options	03/13/2025	03/13/2034	common stock	83,333	0.5	D
Options	03/13/2026	03/13/2034	common stock	83,334	0.5	D
Options	03/13/2027	03/13/2034	common stock	83,333	0.5	D
Options	08/03/2026	10/03/2034	common stock	125,000	0.82	D
Options	08/03/2027	10/03/2034	common stock	125,000	0.82	D
Options	08/03/2028	10/03/2034	common stock	125,000	0.82	D
Options	04/03/2026	10/03/2034	common stock	125,000	0.82	D
Options	09/04/2026	09/04/2035	common stock	12,500	1.58	D
Options	09/04/2027	09/04/2035	common stock	12,500	1.58	D
Options	09/04/2028	09/04/2035	common stock	12,500	1.58	D
Options	09/04/2029	09/04/2035	common stock	12,500	1.58	D

Explanation of Responses:

	/s/ Keeren Shah	05/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.